GlassScriptPhysician profile
Anita Abraham
NPI 1558380337
$1,310.83
in general payments reported to CMS, 2019-2025
14 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $16.57 · 2021: $19.19 · 2022: $14.54 · 2023: $37.65 · 2024: $455 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $333.46 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Novo Nordisk INC | $292.52 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $122.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.83 | 2025 | |
| Dexcom, INC. | $113.24 | 2019-2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $76.01 | 2024-2025 | Minimed 780g |
| Abbott Laboratories | $49.95 | 2024-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $43.53 | 2024 | Nucala |
| Boston Scientific Corporation | $42.69 | 2025 | Watchman Flx |
| Amgen INC. | $27.91 | 2024 | Prolia, Evenity |
| Insulet Corporation | $26.83 | 2025 | Omnipod |
| Lilly USA, LLC | $24.57 | 2019 | |
| Xeris Pharmaceuticals, INC. | $18.99 | 2023 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.27 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.